Updated:
Venture Investors
Clarevia shapes the future of healthcare by discovering and investing in groundbreaking healthcare innovations. Based in the heart of the Midwest, it leverages...
Venture Investors
Clarevia shapes the future of healthcare by discovering and investing in groundbreaking healthcare innovations. Based in the heart of the Midwest, it leverages proximity to world-class research universities and dynamic communities. With decades of experience and $350 million in assets under management, it fuels transformative health solutions that improve lives.
General information
Firm type
Venture Capital
Year founded
1982
Location
Region
North America
Country
United States
City
Madison
Corporate office
Madison, WI, United States
Additional offices
Ann Arbor, MI, United States
Principals
Jim Adox
Managing Director
Scott Button
Managing Director
Dan Malven
Managing Director
Sector focus
Frequently asked questions
Who leads investment decisions at Venture Investors?
Managing directors Jim Adox, Scott Button and Dan Malven lead the firm's investment activity, sourcing and managing portfolio companies from the Madison and Ann Arbor offices. The partnership structure keeps decision-making concentrated among senior professionals with decades of operating and investing experience in the Midwestern ecosystem.
How does Venture Investors source proprietary deal flow?
The firm's sourcing advantage comes from deep embeddedness within the University of Wisconsin–Madison and the University of Michigan research communities. Physical proximity to faculty, graduate researchers, and university technology transfer offices generates deal flow that rarely reaches coastal funds, a structural edge sustained since 1982.
Which sectors does Venture Investors prioritize?
The firm concentrates on digital health, medical devices, enterprise software, and applied artificial intelligence. Healthcare investments span therapeutics, diagnostics, and health IT, often originating from university research, while technology investments include enterprise platforms and select consumer-facing opportunities where the Midwest provides a sourcing edge.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: